Table 1 Guideline Characteristics
From: Guidelines for dementia or Parkinson’s disease with depression or anxiety: a systematic review
Author (year) | Organiz-ation | Primary conditiona | Focus | Region of origin | # of Committee membersi | #of Refs | Systematic search (Y/N) | Grading of evidence (Y/N) | Funding (NS, P, NC, G)j | Mean quality score |
|---|---|---|---|---|---|---|---|---|---|---|
Zesiewicz et al. (2010) [35] | The American Academy of Neurology (AAN) | PD | Treatment | USA | 9 | 40 | Y | Y | NC | 4.5 |
No Author (2010)b [37] | Scottish Intercollegiate Guidelines Network (SIGN) | PD | Diagnosis Treatment | Scotland | 20 | 189 | Y | Y | G | 6 |
Grimes et al. (2012)c [34] | Canadian Neurological Sciences Federation (CNSF) & Parkinson Society Canada | PD | Diagnosis Treatment | Canada | 22 | 62 | Y | Y | NC & P | 6.5 |
Berardelli et al. (2013) [38] | European Federation of Neurological Societies & Movement Disorder Society—European Section (EFNS-MDS-ES) | PD | Diagnosis | Europe | 25 | 245 | Y | Y | NS h | 5 |
Ferreira et al. (2013) [40] | European Federation of Neurological Societies & Movement Disorder Society—European Section (EFNS-MDS-ES) | PD | Treatment | Europe | 22 | 363 | Y | Y | NC | 4.5 |
Hort et al. (2010) [47] | European Federation of Neurological Societies (EFNS) | Dementia | Diagnosis Treatment | Europe | 8 | 100 | Y | Y | NC | 4.25 |
No Author (2010) [42] | Ministry of Health, Social Services and Equality & Agency for Health Quality and Assessment of Catalonia (AIAQS) | Dementia | Diagnosis Treatment | Spain | 67 | 688 | Y | Y | NC & G | 5.75 |
No Author (2011)d [41] | National Institute for Health and Care Excellence, National Collaborating Centre for Mental Health, British Psychological Society & The Royal College of Psychiatrists (NICE) | Dementia | Diagnosis & Treatment | UK | 28 | NNh | Y | Y | NC & G | 6.5 |
Ihl et al. (2011) [44] | World Federation of Societies of Biological Psychiatry (WFSBP) | Dementia | Treatment | International | 39 | 215f | Y | Y | NC | 4.5 |
No Author (2011) [43] | Clinical Research Centre for Dementia (CRCD) | Dementia | Diagnosis | South Korea | 20 | NNh | Y | Y | G | 5.25 |
O’Brien et al. (2011) [60] | British Association of Psychopharmacology (BPA) | Dementia | Treatment | UK | 16 | 148f | N | Y | NC & P | 4 |
Sorbi et al. (2012) [45] | European Federation of Neurological Societies & European Neurological Society (EFNS-ES) | Dementia | Diagnosis Treatment | Europe | 17 | 189 | Y | Y | NC | 4.5 |
Gauthier et al (2012)e [50] | Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4) | Dementia | Diagnosis Treatment | Canada | 38 | 19 | Y | Y | NC | 5.5 |
Gelenberg et al. (2010)g [39] | American Psychiatric Association (APA) | Depression | Treatment | USA | 7 | 1170 | Y | Y | NC | 4.75 |
Dua et al. (2011) [49] | World Health Organization (WHO) | Mental Health | Diagnosis Treatment | International | 29 | 36 | Y | Y | NC & G | 5.5 |
No Author (2012) [46] | Ministry of Health, Social Services and Equality & Galician Health Technology Assessment Agency (Availia-T) | Suicide | Diagnosis Treatment | Spain | 24 | 683 | Y | Y | NC & G | 5 |
Mitchell et al. (2013) [48] | Institute for Clinical Systems Improvement (ICSI) | Depression | Diagnosis Treatment | USA | 14 | 331 | Y | Y | NC | 5.75 |